Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials

BACKGROUND: Intermittent (luteal phase) dosing of selective serotonin reuptake inhibitors is one treatment strategy for premenstrual syndromes such as premenstrual dysphoric disorder. This avoids the risk of the antidepressant withdrawal syndrome associated with long-term continuous dosing. AIMS: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilly, Thomas J, Wallman, Phoebe, Clark, Ivana, Knox, Clare-Louise, Craig, Michael C, Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074750/
https://www.ncbi.nlm.nih.gov/pubmed/35686687
http://dx.doi.org/10.1177/02698811221099645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074750/
https://www.ncbi.nlm.nih.gov/pubmed/35686687
http://dx.doi.org/10.1177/02698811221099645

Ejemplares similares